Population and target considerations for triple-negative breast cancer clinical trials.

Hyslop T, Michael Y, Avery T, Rui H. Population and target considerations for triple-negative breast cancer clinical trials. Biomark Med. 2013 Feb; 7(1):11-21.

View in: PubMed